Hypertriglyceridemia News and Research

RSS
Hypertriglyceridemia refers to the condition where there are high blood levels of triglycerides, the most abundant fatty molecule in most organisms. It has been associated with atherosclerosis, even in the absence of hypercholesterolemia (high cholesterol levels). It can also lead to pancreatitis in excessive concentrations.
Postmenopausal breast cancer survivors at greater risk for developing heart disease

Postmenopausal breast cancer survivors at greater risk for developing heart disease

New molecule could help fight type 2 diabetes and non-alcoholic fatty liver disease

New molecule could help fight type 2 diabetes and non-alcoholic fatty liver disease

Epigenetic link found between prenatal exposure to maternal smoking and offspring's cardio-metabolic health

Epigenetic link found between prenatal exposure to maternal smoking and offspring's cardio-metabolic health

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

Pancreatitis risk in minorities linked to alcohol, gallstones and high triglycerides

Pancreatitis risk in minorities linked to alcohol, gallstones and high triglycerides

Endoscopic sleeve gastroplasty found to be safe and effective way for treating obese patients

Endoscopic sleeve gastroplasty found to be safe and effective way for treating obese patients

ULCA scientists discover how autoantibodies cause some cases of severe hypertriglyceridemia

ULCA scientists discover how autoantibodies cause some cases of severe hypertriglyceridemia

Low normalized grip strength linked to cardiometabolic diseases and disabilities in adults

Low normalized grip strength linked to cardiometabolic diseases and disabilities in adults

Experimental lipid-lowering drug improves glucose control in diabetic patients

Experimental lipid-lowering drug improves glucose control in diabetic patients

First generic version of Crestor gets FDA approval

First generic version of Crestor gets FDA approval

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

Blocking the expression of certain gene reduces excessive fat in patients

Blocking the expression of certain gene reduces excessive fat in patients

Infants born with mutation in PLVAP gene develop severe protein losing enteropathy

Infants born with mutation in PLVAP gene develop severe protein losing enteropathy

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders

FDA approves CHOLBAM (cholic acid) for treatment of bile acid synthesis disorders

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

Upregulating heme-oxygenase with hemin helps improve pericardial adipocyte morphology, function

Upregulating heme-oxygenase with hemin helps improve pericardial adipocyte morphology, function

Pembrolizumab shows promising results in patients with classical Hodgkin Lymphoma

Pembrolizumab shows promising results in patients with classical Hodgkin Lymphoma

Ranbaxy obtains FDA approval to manufacture, market Fenofibrate Capsules USP, 43 mg and 130 mg

Ranbaxy obtains FDA approval to manufacture, market Fenofibrate Capsules USP, 43 mg and 130 mg